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Exposure Utilization and Completion of Cognitive Behavioral
Therapy for PTSD in a “Real World” Clinical Practice
Claudia Zayfert,1,2,6 Jason C. DeViva,1,4 Carolyn B. Becker,3 Julie L. Pike,1
Karen L. Gillock,1 and Sarah A. Hayes1,5

This study assessed rates of imaginal exposure therapy (ET) utilization and completion of cognitive
behavioral therapy (CBT) for posttraumatic stress disorder (PTSD) in a clinical setting and examined
variables associated with CBT completion. Using a clinical definition, the completion rate of CBT
was markedly lower than rates reported in randomized trials. CBT completion was inversely related
to severity of overall pretreatment measures of PTSD, avoidance, hyperarousal, depression, impaired
social functioning, and borderline personality disorder. Regression yielded avoidance and depression
as unique predictors of completion. Most dropouts occurred before starting imaginal ET, although
initiating ET was associated with greater likelihood of completion. Results highlight methodological
differences between research and practice notions of treatment completion and the need for further
study of variables influencing CBT completion in practice settings.

Cognitive behavioral therapy (CBT), consisting of
exposure therapy (ET) and cognitive restructuring (CR),
is the most systematically studied psychosocial intervention for posttraumatic stress disorder (PTSD)(Rothbaum,
Meadows, Resick, & Foy, 2000). Despite extensive empirical support for ET, several authors have noted concerns
about its implementation for PTSD in clinical practice
(Foy et al., 1996; Litz, Blake, Gerardi, & Keane, 1990). A
recent survey of psychologists (Becker, Zayfert, & Anderson, 2004) investigated clinician utilization of ET. Results
indicated that, of a sample of 207 psychologists, only 17%
used imaginal ET to treat PTSD. Amidst their concerns,

59% harbored a belief that using ET was likely to increase
patients’ desire to drop out of treatment. This figure was
also quite high (nearly 50%) among 29 CBT trauma specialists. Thus, concern about dropout was a significant
issue even among psychologists with a special interest
in PTSD, background in behavior therapy, and a likely
affinity for empirically supported, structured psychotherapy. Valid or not, clinicians’ perception that ET will be
associated with elevated dropout rates may influence dissemination of ET into broad clinical practice.
Recently, Feeny, Hembree, and Zoellner (2003) dismissed concerns about dropout from ET for PTSD as
myth. They supported this position in large part by noting
that ET is not associated with higher dropout rates than
other forms of CBT in randomized clinical trials (RCTs;
Hembree et al., 2003). Yet, rates of dropout from all forms
of CBT were higher than from non-CBT interventions,
and Hembree et al. speculated that structured treatments
may limit therapists’ attention to patient comfort and other
concerns, thus increasing dropout. Moreover, despite no
differences in relative dropout in RCTs of CBT, we contend that it is premature to set aside concerns regarding
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absolute dropout levels from any form of CBT for PTSD
in clinical practice. Although PTSD RCTs form a crucial
base of empirical support for CBT, their applicability to
PTSD dropout in clinical settings may be limited.
The external validity of RCT dropout rates can
be addressed empirically, and data support the external validity of RCT dropout rates for some disorders
(e.g., obsessive-compulsive disorder [OCD]; Franklin,
Abramowitz, Kozak, Levitt, & Foa, 2000). However, research on CBT for other disorders, such as depression
(Persons, Burns, & Perloff, 1988) and bulimia nervosa
(Steel et al., 2000; Waller, 1997), indicates that dropout
rates in clinical practice can be as high as twice the
highest RCT rate. Reported dropout rates from CBT
for PTSD range from 0% (Glynn et al., 1999) to 43%
(Power et al., 2002). In other words, the highest RCT
dropout rate from CBT for PTSD hovers around 40%.
If the difference between RCT and clinical practice
dropout rates from CBT for PTSD proves to be similar to the differences for depression and bulimia nervosa, we may expect to find an 80% dropout rate from
CBT for PTSD in clinical practice. Although the similarity between clinical practice and RCT dropout rates
in OCD raises the possibility that anxiety disorders,
including PTSD, may not show the disparity seen in
bulimia and depression, findings of Wade, Treat, and
Stuart’s (1998) panic disorder benchmarking study, in
which results from a mental health center were compared
to those of two published RCTs, do not bear this out. Wade
et al. reported a 26.4% dropout rate. In comparison, the
two RCTs were associated with 0% (Telch et al., 1993)
and 6% (Barlow, Craske, Cerny, & Klosko, 1989) dropout.
To our knowledge, only two published studies have
investigated clinical-practice dropout rates of individuals
with PTSD or traumatic event survivors. Fisher, Winne,
and Ley (1993) found a 41% dropout rate from group
therapy among 54 depressed childhood sexual abuse survivors at a mental health center. Burstein (1986) found
a 46% dropout rate among PTSD private-practice patients receiving medication and supportive psychotherapy. There was, however, a linear relationship between
chronicity and dropout, with 82% of those who were 41
weeks or more posttraumatic event dropping out of treatment. Of note, the 41% to 46% dropout rates found by
Burstein and by Fisher et al. were not from CBT. Hembree et al. (2003) found that CBT generally results in
higher dropout rates in RCTs, compared to less structured
therapies. Burstein’s and Fisher et al.’s findings were,
however, similar to dropout rates from studies of CBT
for other disorders in clinical settings severity (Persons
et al., 1988; Steel et al., 2000; Waller, 1997), as well
as meta-analyses of dropout in general clinical settings
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(Wierzbicki & Pekarik, 1993). Assessment of dropout
rates in clinical settings, because it will enable clinicians’ concerns to be refuted or validated and addressed,
is an important step in promoting use of CBT in clinical settings. Yet, no such data are available; dropout
from CBT for PTSD in clinical practice remains unknown.
Identification of factors associated with dropout may
facilitate targeting interventions to aid treatment completion in clinical settings. Several studies have reported
predictors of dropout from CBT for PTSD in RCTs
(Bryant, Moulds, Guthrie, Dang, & Nixon, 2003; Taylor,
Fedoroff, & Koch, 1999; van Minnen, Arntz, & Keijsers,
2002). Taylor et al. found that dropout was associated with
pretreatment anxiety, depression, guilt, severity of PTSD,
comorbidity, a perception of decreased control, and ongoing stress. Although Taylor et al. did not assess personality
disorders, they noted that therapists often used crisis management to help patients cope with life stressors. Bryant et
al. found that dropouts reported higher depression, PTSD
avoidance, and anxiety. Van Minnen et al. found that gender, trait anxiety, and alcohol and benzodiazepine use were
associated with dropout from ET.
Because completion1 of CBT for PTSD in clinical
practice has not yet been empirically examined, a review
of studies of factors influencing completion of CBT for
other disorders in clinical practice offers useful information about the variables that may affect completion of
CBT in naturalistic settings. Borderline personality disorder (BPD) symptoms were found to predict dropout from
CBT for bulimia nervosa (Steel et al., 2000; Waller, 1997).
Personality disorders in general were related to dropout
in studies of cognitive therapy for depression (Persons
et al., 1988) and generalized anxiety disorder (Sanderson,
Beck, & McGinn, 1994) in clinical settings. Pretreatment
depression severity (Persons et al., 1988; Steel et al.) and
external locus of control (Steel et al.) also significantly
predicted dropout in clinical settings. Thus, we might expect BPD and depression severity to be associated with
dropout from CBT for PTSD in clinical practice, as well.
In addition, based on prior data indicating frequent comorbidity of social phobia with PTSD in our clinical practice
(Zayfert, Becker, Unger, & Shearer, 2002), and the wellrecognized association of social anxiety with avoidance
of situations that focus attention on the self, we speculated
that social phobia would also affect treatment completion.
The present study had several objectives. First, because no previous studies have reported completion rates
of CBT for PTSD in clinical practice, our primary
1 Although

“dropout” is most commonly employed, the term “completion” more accurately reflects patient behavior in clinical practice settings (see completion definition below).

Completion of CBT for PTSD
objective was to assess the treatment completion rate in
a clinical sample of patients receiving CBT for PTSD.
The CBT protocol used in our clinic includes both imaginal and in vivo exposure. Given the high incidence of
childhood abuse in our clinic population, we based our
expectation on dropout rates reported in RCTs of childhood abuse survivors ranging from 30% (Cloitre, Koenen,
Cohen, & Han, 2002) to 40% (McDonagh-Coyle et al.,
2001). Thus, because reported dropout rates for CBT
for some disorders in clinical settings have been double the rates reported in RCTs for those same disorders,
we expected that the completion rate for this population
might be as low as 20%. Second, we aimed to assess
the rate of participation in imaginal ET, deemed an essential treatment component, and examine its association
with dropout. Finally, we sought to explore other variables that might be associated with completion of CBT in
clinical practice. We hypothesized that, among variables
assessed, severity of PTSD avoidance symptoms, depression, social anxiety, and BPD would be associated with
treatment completion.

Method
Setting
Founded in 1990, the Anxiety Disorders Service
(ADS) of Dartmouth Hitchcock Medical Center is a specialty CBT clinic within a tertiary care medical center in
rural New Hampshire, United States. During the study period the clinic was staffed by 12 doctoral psychologists (9
postdoctoral fellows, 2 staff psychologists) and one predoctoral intern, all of whom received their doctoral and
internship training from established programs in behavioral psychology. Many also had specialized training in
CBT for anxiety disorders. The clinic director (C.Z.) received specialized training in CBT for PTSD through the
National Center for PTSD.
The mission of the ADS is to deliver CBT to as many
patients presenting with PTSD as possible, regardless of
gender, traumatic event type, or comorbidity. Therefore,
the only exclusionary criteria are active substance dependence and behaviors that pose a threat to physical safety. In
cases where behaviors associated with BPD cause more
functional interference than PTSD, patients are considered principal BPD and are referred for dialectical behavior therapy (DBT) and encouraged to return for PTSD
treatment if needed.
For the purpose of this paper, we believe it is helpful
to describe the science/practice blend of the clinic, which
may be somewhat unusual. In terms of scientific orienta-
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tion, all of the clinicians were strongly oriented towards
delivering empirically supported treatment and committed
to using structured clinical interviews as part of standard
clinical assessment to facilitate quality care and clinical
research, and most had experience with protocol-driven
treatment. Based on the research supporting the efficacy
of ET, imaginal and in vivo ET are considered essential
components of treatment, and therapists are actively encouraged to engage patients in ET.
Because the clinic is not research-funded, however,
clinicians operate under standard U.S. clinical practice
conditions. Psychologists log 29 clinical hours per week;
postdoctoral fellows log 18 hours. Third-party reimbursement is standard, and treatment continues until therapist
and patient agree to terminate, external factors interfere
with treatment, or the patient drops out without explanation. Therapists are required to navigate a range of insurance policies, and treatment often has to conform to the
reimbursement limitations. For example, sessions longer
than 50 minutes or delivered more often than weekly typically are not reimbursed. Thus, treatment is adapted to
fit the constraints of payers as well as patients’ schedules.
Finally, it is important to note that, because of the rural
setting, access to CBT is limited and thus, there is pressure to take all comers many of whom travel a significant
distance.
Participants
Participants were drawn from among 793 consecutive ADS evaluations. One-hundred fifty patients (19%)
were assigned a principal diagnosis of PTSD. We did not
include 52 patients who were assigned PTSD comorbid to
another principal disorder. Of 150 patients with principal
PTSD, 6 (4%) were referred to DBT. Twenty-five (17%)
did not return after evaluation, leaving 119, 4 (3%) of
whom remain in active treatment and are excluded from
the analyses, resulting in a final sample of 115.
Treatment
Treatment consisted of recommended components of
CBT for PTSD (Foa & Rothbaum, 1998) administered in
individual sessions, typically beginning with psychoeducation and breathing retraining. In vivo and imaginal ET (a
minimum of seven sessions) were recommended for most
patients and CR was typically included as well. When
deemed necessary, other techniques were used, including assertiveness training, activity scheduling, problem
solving, and elements of DBT such as validation, mindfulness, and self-soothing. Forty-two percent of patients who
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began treatment participated in one or more sessions of
an adjunctive CBT group that included psychoeducation,
sharing experiences with exposure, discussing consequences of avoidance, and CR. As in most clinical settings, patients did not receive a predetermined number or
type of sessions, but rather received varying numbers of
sessions including the above components as determined
by their presenting symptoms. In some instances, comorbid disorders, such as depression or BPD, were targeted
simultaneously with PTSD. The length, frequency, and
number of sessions were influenced by real world factors
such as patients’ scheduling needs, health problems, or
constraints of third party reimbursement.
Treatment Completion
Because treatment was provided in a clinical setting and not as part of funded research, completion was
not conceptualized as the delivery of a specific dosage of
treatment. Rather, this study used the clinical definition of
treatment completion employed in other clinical practice
studies (Persons et al., 1988). Patients were coded as completing treatment when they and their therapist determined
that they had met their PTSD treatment goals. Typically,
treatment goals were met when the traumatic memories
no longer evoked emotional distress or physical reactions
and the patient no longer reported nightmares or flashbacks. In other words, treatment was typically considered
complete when the patient no longer met the reexperiencing diagnostic criterion and when patient and therapist
were satisfied with the outcome of treatment. Although
treatment plans typically included imaginal ET, in some
cases treatment goals were achieved via CR, or in vivo
ET, without the patient receiving a session of imaginal
ET meeting the definition below. Similarly, some patients
received more treatment sessions than they would have
in RCTs of CBT for PTSD but were coded as dropouts
because treatment goals had not been met (e.g., reexperiencing symptoms persisted when they left treatment).
Although this definition is conservative relative to definitions typically employed in RCTs, it is consistent with
the manner of clinical decision making that occurs in real
world practice situations.
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ET, although routinely employed, was not included in the
ET categorization.
Measures
Anxiety Disorders Interview Schedule
The ADIS-IV-R (Brown, DiNardo, & Barlow, 1994)
is a semistructured clinical interview that Page (1991)
deemed the most appropriate instrument for a comprehensive and reliable assessment of anxiety disorders. The
PTSD section was modified to include (a) a standard probe
question for traumatic life events adopted from the Clinician Administered PTSD Scale (CAPS; Blake et al., 1995)
followed by the query, “Which event is the worst? Which
event bothers you the most?” and (b) the CAPS probes
for the 17 PTSD symptoms. The ADIS-IV-R was supplemented with a structured checklist of Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV) criteria
for BPD that the interviewer reviewed with the patient.
Clinician-Administered PTSD Scale
The CAPS (Blake et al., 1995), widely considered the
gold standard for assessing PTSD, was used to measure
PTSD severity. The CAPS provides severity ratings for
17 PTSD symptoms that can be summed to yield severity scores for the reexperiencing (CAPS-B), avoidance
(CAPS-C), and arousal (CAPS-D) symptom clusters, as
well as a total PTSD severity score (CAPS-Total).
Beck Depression Inventory (BDI)
The BDI (Beck, Ward, Mendelson, Mock, &
Erbaugh, 1961) is a 21-item self-report measure of depressive symptoms with good internal consistency, test–retest
reliability and construct validity.
Medical Outcomes Study 36 Item Short-Form Health
Survey (SF36)
The SF36 (Ware & Sherbourne, 1992) is a widely
used measure of health functioning. This study examined
the social functioning scale score (SF). Lower scores indicate worse functioning.

Imaginal ET Utilization
Procedure
Because we wanted to determine whether initiating
imaginal ET was associated with completion, we coded
patients as positive for utilization if they completed at least
one session of imaginal ET, defined as at least 30 minutes
of traumatic memory verbalized by the patient. In vivo

Measures were administered as part of a comprehensive clinical evaluation to develop treatment
recommendations. The BDI and SF36 were among a
packet of self-report measures mailed to patients prior to
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their appointments. Based on the ADIS-IV-R results and
ratings of functional interference and distress, patients
were assigned a principal diagnosis and applicable comorbid diagnoses. Subsequently, the assigned treatment
clinician administered the CAPS to measure PTSD severity prior to starting treatment. With the approval of the
Institutional Review Board for Protection of Human Subjects, data were gleaned from retrospective chart review
of consecutive evaluations.
Data Analysis
The CAPS total, CAPS subscale, BDI and SF scores
of patients who were coded as completing treatment were
compared to dropouts, using t tests. Chi-square analyses were used to examine frequency of childhood abuse,
BPD, comorbid depression, and comorbid social phobia.
Variables that differed for completers and dropouts were
entered into a logistic regression equation to determine
which contributed uniquely to treatment completion.
Results
Sample Characteristics
The sample consisted of 115 patients who began
treatment and either completed or dropped out of treatment. The mean age of this subset was 37.8 years (SD =
11.3), 82% were female, 57% were married/cohabitating,
60% were employed, 94% were Caucasian, and mean
years of education was 13.2 (SD = 2.4). Eighty-four percent carried at least one additional Axis I diagnosis; 71%
met one or more comorbid anxiety or mood disorders on
the the criteria for ADIS-IV-R (M = 1.4, SD = 1.2). Sixtyfour percent reported childhood physical or sexual abuse
and 34% met diagnostic criteria for BPD. The primary
traumatic event types were childhood abuse (sexual 50%;
physical 10%), adult abuse/assault (sexual 10%; physical
10%), accidents (10%), and other (11%), although most
reported multiple traumatic events. Patients who began
treatment did not differ from those who did not return after evaluation, on any demographic or psychometric variables, frequency of childhood abuse, or comorbid BPD.
Rates of Treatment Completion and Imaginal
ET Utilization
Of the 115 patients, 48 (42%) were coded as having
started imaginal ET2 and 32 (28%) were coded as treat2A

subset of these data was reported in Zayfert and Becker (2000).
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Table 1. Number of Treatment Sessions Received for Imaginal Exposure Therapy, Individual Therapy, and Group Therapy;
Mean (SD) Range
Completers
(n = 32)

Therapy
Imaginal exposure therapy sessions
Total individual sessions
PTSD group sessions

6.1 (5.0)
0 – 20
28.3 (17.5)
6 – 76
5.5 (6.2)
0 – 23

Dropouts
(n = 83)

t

.8 (2.3)
7.7∗∗∗
0 – 18
16.0 (16.1) 3.6∗∗
0 – 70
2.8 (4.3) 2.6∗
0 – 20

Note. PTSD = posttraumatic stress disorder.
∗ p < .05. ∗∗ p < .01. ∗∗∗ p < .001.
Table 2. Pretreatment Psychometric Scores for Treatment Completers
and Dropouts, Mean (SD, n)
Measure
CAPS-B
CAPS-C
CAPS-D
CAPS Total
BDI
SF36-SF

Completed

Dropped out

t

19.2 (8.8, 30)
25.2 (8.4, 30)
22.6 (7.8, 30)
67.0 (19.5, 30)
21.4 (8.0, 27)
33.9 (13.4, 21)

22.7 (8.1, 64)
33.8 (9.8, 64)
26.6 (6.5, 64)
83.2 (21.0, 64)
29.3 (10.2, 72)
27.0 (10.1, 67)

1.91
4.13∗∗∗
2.64∗
3.67∗
3.64∗∗∗
2.53∗

Note. CAPS = Clinician-Administered PTSD Scale; BDI = Beck Depression Inventory; SF36-SF = Social Functioning scale of Medical
Outcomes Questionnaire Short Form-36.
∗ p < .05. ∗∗∗ p < .001.

ment completers (Table 1). Significantly more of those
who started imaginal ET went on to complete treatment
(58%), compared to patients who did not receive imaginal
ET (6%), χ 2 (1, N = 115) = 38.18, p < .001. Seventy-six
percent of those who dropped out did so before starting
exposure. Because dropouts received on average 16 individual sessions, we decided to see how many of the
24% of dropouts who started imaginal ET met the typical
seven ET session requirement of RCTs. Only one dropout
received more than six sessions of imaginal exposure, suggesting that most would not have been completers in an
ET condition of an RCT. In contrast, 87% of completers
started ET and 38% received seven or more imaginal exposure sessions.
Factors Associated With Completion
Table 2 shows pretreatment characteristics of patients
who completed treatment and those who dropped out.
Dropouts reported more PTSD avoidance, greater arousal,
higher overall PTSD severity, more severe depression, and
more impaired social functioning at intake. Dropouts were
not more likely to have a history of childhood abuse (66%
vs. 59% of completers), major depressive disorder (63%
vs. 50% of completers), or social phobia (42% vs. 38% of
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completers), although they were more likely to have met
criteria for BPD (40% of dropouts vs. 19% of completers),
χ 2 (1, N = 115) = 4.60, p ≤ .05.
Logistic Regression Predicting Treatment Completion
Because the occurrence of treatment completion limited the number of possible regression predictors to three,
we selected CAPS-C, BDI score, and BPD on the basis
of bivariate association with completion and prior research. We entered all three variables into a logistic regression equation using the Forward Wald method. CAPS-C,
OR = .910, CI = .862–.961, and BDI score, OR = .932,
CI = .874–.995, emerged as significant predictors of
completion, together accounting for 29% of variance
(Nagelkerke R2 ).

Discussion
Our first objective was to assess the rate of completion of CBT in a clinical setting with few exclusion criteria
using a typical clinical definition of completion (i.e., patients remain in treatment until the desired outcome is
achieved). The completion rate observed using these parameters (28%) was markedly lower than rates reported
in RCTs (Hembree et al., 2003), yet higher than the rate
we predicted (20%). Several factors may account for this
finding. First, using the clinical definition of treatment
completion, which inherently links treatment completion
to positive outcome, is likely to produce a conservative
estimate of completion. Note that, on average, dropouts
participated in 16 individual therapy sessions, and one
in four dropouts started imaginal ET. This suggests that
many such patients might have been coded as completers
(but perhaps also nonresponders) had they been RCT participants in a no ET condition rather than patients in a
clinic.
Second, the overall rate of BPD diagnosed among
patients with PTSD treated in this setting was three times
that reported in a recent RCT (Feeny, Zoellner, & Foa,
2002). Patients who dropped out were twice as likely as
completers to carry a BPD diagnosis. It is possible that
structured CBT presents unique challenges for patients
with BPD, a point illustrated by Linehan’s (1993) development of DBT. Third, many patients are referred to
this clinic for other problems and may therefore be particularly ambivalent about treatment for PTSD. Although
many such patients do not return after the evaluation,
clinicians often are successful in persuading patients to
attend an initial session to learn more about CBT, yet not
in retaining them further.
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Overall, starting imaginal ET was associated with a
higher likelihood of treatment completion (nearly 60%),
and treatment completers received significantly more sessions of ET than dropouts. Yet, 76% of patients who
dropped out did so before starting imaginal exposure.
Given that in this clinic the main treatment goal is to
deliver ET, these results suggest that treatment was not
successfully implemented with the majority of patients.
Further, among patients who started exposure, over 40%
did not complete treatment. Causal relationships are uncertain, however; failure to start ET may lead to dropout,
or therapists may refrain from implementing ET with patients who appear at risk for dropout.
One interesting question raised by these data concerns standards of care in clinical practice. If clinical
practice is associated with dropout rates approximately
twice those of RCTs, then one possible interpretation is
that clinical practice should operate more like an RCT in
order to improve patient retention. Although we believe
that there is some truth to this, we also see two problems
with this interpretation. First, the contingencies of clinical
practice make it difficult to operate a clinical practice like
an RCT as payers often prohibit treatment formats delivered in RCTs. Second, RCTs are associated with significant early dropout (Kazdin, 2003). In other words, many
ambivalent patients drop out prior to randomization. For
example, when participants who were assigned to no treatment were subtracted out, only 39% of the women who
were fully evaluated and met criteria for PTSD completed
treatment in the Cloitre et al. study (2002). Given that the
present sample included BPD patients, whereas the Cloitre
et al. sample did not, the 28% completion rate does not
appear that different, suggesting that early dropout may
comprise a substantial segment of clinical dropout that is
not accounted for in RCT dropout rates. Yet, as clinicians,
our goal should not be to improve our dropout rate artificially by encouraging ambivalent patients to disengage
prior to the first session; rather, research should identify
strategies to engage these patients in treatment so that they
may benefit from the interventions that have worked so
well in RCTs.
Treatment completion was related to comorbid
BPD, greater depression, avoidance, hyperarousal, overall PTSD severity and social impairment, but not major
depressive disorder, social phobia diagnosis, or history of
childhood abuse. The patterns suggest that the strength of
the relationships of depression, social anxiety, and BPD
with completion may be obscured when measured dichotomously. The finding that PTSD avoidance and severity of depression were associated with CBT completion
is consistent with reported dropout predictors from RCTs
of CBT for PTSD (Bryant et al., 2003). Together with the
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role of BPD, it is also consistent with studies of dropout
from CBT for other disorders in clinical practice (Persons
et al., 1988; Sanderson et al., 1994; Steel et al., 2000;
Waller, 1997). These findings suggest that a treatment approach that directly addresses avoidance, social isolation,
and depression, and accommodates other needs of individuals with BPD, may be associated with greater rates of
treatment completion.
PTSD avoidance symptoms uniquely predicted treatment completion. It may be that individuals who are more
avoidant are more likely to express reluctance to begin
ET or exhibit behaviors that inhibit therapists from initiating ET. Patients who did not start imaginal ET were
less likely to complete treatment and it is possible that
this reflects avoidance of direct engagement with trauma
stimuli, which is required during ET. Depressive symptoms also uniquely predicted completion. Depression may
engender hopelessness about treatment, which might lead
to dropout. It is also possible that a third variable may
account for the relationships of avoidance and depression
with treatment completion. For example, perception of
decreased control, which has been implicated in the etiology of PTSD (Ehlers & Steil, 1995; Foa, Zinbarg, &
Rothbaum, 1992), has also been prominent in theories of
depression. It is possible that depression is associated with
low perceived control, that avoidance reflects efforts to
exert control, and that structured trauma-focused therapy
diminishes perceived control over unpleasant emotions
associated with the trauma and/or the therapy process,
leading to dropout. Depressed individuals may be more
likely to avoid structured treatment such as CBT if they
perceive that the structure diminishes their ability to control what happens in treatment.
These findings illustrate an important methodological difference between research and practice notions of
dropout and treatment completion. The concept of dropout
as assessed in RCTs may not have a direct relationship to
how it is understood in clinical practice. This conceptual mismatch between research and practice definitions
of treatment completion may affect clinicians’ perceptions
of the relevance of research findings to their practice experience. For example, reports of low dropout rates based on
patients randomized to studies may mislead clinicians into
expecting similar, and unrealistically low, rates of dropout
in clinical practice. If clinicians subsequently experience
higher dropout rates, they may abandon ET because a)
the clinicians blame the treatment and b) researchers imply that clinicians are doing a poor job of implementing
the treatment, thus invalidating clinicians’ experiences.
In fact, however, the problem may be that RCTs underestimate the problem of PTSD dropout in clinical practice. Smucker, Grunert, & Weis (2003) raise concerns that
there has been a tendency in the field to attribute treat-
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ment failures largely to inadequate implementation of ET
as opposed to a focus on systematically identifying factors that may lead to poor outcome. As proponents of ET,
we share Smucker et al.’s perspective that dissemination
will be enhanced by greater effort on the part of the research community to identify and address barriers faced
by clinicians implementing CBT for PTSD.
Several limitations to the present study must be acknowledged. For example, the homogeneity of the sample may limit generalizability to more diverse populations, and the sample size limited the variables included
in the regression analysis. Additionally, because this was
a study of therapy in a clinical setting, it differed from
RCTs in important ways. First, due to real-life constraints
such as insurance mandates and patient availability and
needs, treatment was not as standardized as in RCTs. The
number, length, distribution, and content of sessions were
more heterogeneous than in RCTs. This sacrifice of internal validity is, however, inherent in a naturalistic study
that aims to maximize external validity. Second, due to the
difficulties achieving adherence to structured assessments
in clinical settings, all data were not available for all patients. Third, interrater reliability data were not available
for the interview assessments. Fourth, in most cases, the
diagnosis of BPD was not via an established instrument
and BPD severity was not measured; thus, conclusions
involving BPD should be viewed as tentative. Likewise,
severity of social anxiety was not assessed. Finally, no
outcome data were available for dropouts; therefore, it is
not possible to firmly conclude that these patients did not
improve from treatment.
In summary, the completion rate observed in this
study, 28%, although disturbingly low, was better than
expected based on data from naturalistic studies of CBT
for other disorders and RCTs of CBT for PTSD. Because completion is contingent upon achieving clinical
goals, clinic-defined treatment completion actually reflects a composite of retention and positive outcome.
Therefore dropout rates presented should be viewed as
liberal estimates relative to those reported in RCTs. These
data should be corroborated with data from other clinic
settings and populations. Nonetheless, they suggest that,
when translated into real world practice settings, the average dropout rate of 27% from RCTs of CBT for PTSD
(Hembree et al., 2003) may produce a substantially lower
yield of successful treatment cases. Patients who complete
CBT clearly benefit from the interventions, yet we found
that a majority did not start imaginal ET and most abort
prematurely. Premature attrition may occur because patients perceive that they are not benefiting, because they
find reversing their avoidance too difficult, or because
depression impedes their ability to adhere to the demands
of treatment. In some cases, other life problems take
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priority over treatment of PTSD. The data indicate that
starting imaginal ET was associated with a greater likelihood of completing. Yet, most attrition occurred prior to
starting imaginal ET, suggesting that expectations and beliefs about treatment may have had a greater influence on
treatment adherence than actual experience with imaginal
ET. Developing strategies to address possible misconceptions patients have about PTSD treatment may increase
willingness to engage in structured trauma-focused interventions. Future research should develop means of addressing the variety of challenges that interfere with treatment engagement and examine whether available empirically supported tools can be effective in helping clinicians
to stay the course rather than abandon ET.
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